# Sandoz Narrows Sales Forecast and Raises Margin Outlook

The drugmaker reported 5% quarterly sales growth at constant currencies, led by biosimilars and North America.

By Will Langan | 24X7 News
Published: 2026-10-28T07:06:40.601Z
Updated: 2026-10-28T07:06:40.601Z
Section: Business
Format: News
Canonical: https://24x7news.us/articles/sandoz-third-quarter-sales-outlook-october-28-2026

Sandoz narrowed its 2026 sales-growth forecast while raising its expected profit margin on October 28, citing supply constraints and challenging short-term conditions in Germany alongside stronger biosimilar sales.

The company now expects net-sales growth of 5%–6% at constant currencies, compared with its previous mid-to-high single-digit range. Its core EBITDA margin is forecast at 23%–23.5%. That adjusted earnings measure excludes specified items and is distinct from reported net profit.

Third-quarter net sales were $2.942 billion, up 4% in dollars and 5% at constant currencies, according to the company’s regulated announcement.

Biosimilar sales reached $998 million, increasing 17% at constant currencies and accounting for 34% of quarterly sales. Generic-drug sales were $1.944 billion and were stable at constant currencies.

North American sales increased 20% at constant currencies, led by biosimilars. Sandoz said near-term biosimilar supply constraints and unfavorable market conditions in Germany partly offset growth elsewhere.

The revised full-year figures remain forecasts. The completed sales results cover the quarter ended September 30.

Sources
Sandoz regulated announcement, October 28, 2026: https://www.eqs-news.com/de/news/ad-hoc/sandoz-reports-strong-biosimilar-sales-momentum-narrowed-full-year-net-sales-range-and-upgrade-to-margin-guidance/35fd8902-04bc-41d9-bf50-3e985c228aca_en

## Sources
- Sandoz — regulated sales announcement through EQS, October 28: https://www.eqs-news.com/de/news/ad-hoc/sandoz-reports-strong-biosimilar-sales-momentum-narrowed-full-year-net-sales-range-and-upgrade-to-margin-guidance/35fd8902-04bc-41d9-bf50-3e985c228aca_en